MADRID -- Stopping oral anticoagulation after successful ablation for atrial fibrillation (AF, Afib) improved outcomes for patients without documented recurrence, the randomized ALONE-AF trial showed.
Discontinuing oral anticoagulation (OAC) therapy resulted in a lower risk of a composite of stroke, systemic embolism or major bleeding than continuing OAC therapy in patients who had successful ...
MedStar Heart & Vascular Institute now offers patients with irregular heart rhythm a minimally invasive option to reduce the risk of stroke, as well as enable stopping long-term use of blood thinning ...